Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Pizzuti

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
Tumori|October 26, 2013
Unusual long-lasting cutaneous complete response to lapatinib and capecitabine in a heavily pretreated HER2-positive plurimetastatic breast cancer patientLaura Pizzuti, Domenico Sergi, Maddalena Barba, et al.
Immunotherapy|June 4, 2020
Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitorsPatrizia Vici, Laura Pizzuti, Eriseld Krasniqi, et al.
Journal of Clinical Medicine|February 21, 2019
Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast CancerMarco Mazzotta, Eriseld Krasniqi, Giacomo Barchiesi, et al.
Medicine|August 7, 2020
Case report: 5-year progression free survival and complete liver response in a patient with metastatic breast cancer treated with everolimus plus exemestaneEriseld Krasniqi, Giacomo Barchiesi, Marco Mazzotta, et al.
International Journal of Medical Sciences|April 16, 2021
Burnout of health care providers during the COVID-19 pandemic: Focus on Medical OncologistsPatrizia Vici, Eriseld Krasniqi, Laura Pizzuti, et al.
Frontiers in Oncology|July 31, 2023
Prognostic value of [18F]-FDG PET/CT in patients with meta-static breast cancer treated with cyclin-dependent inhibitorsAlessio Annovazzi, Sandra Rea, Daria Maccora, et al.
Anticancer Research|August 5, 2006
Tissue microarray analysis of FAS, Bcl-2, Bcl-x, ER, PgR, Hsp60, p53 and Her2-neu in breast carcinomaValeria Sebastiani, Claudio Botti, Ugo Di Tondo, et al.
Medicine|September 14, 2019
Highly durable response to capecitabine in patient with metastatic estrogen receptor positive breast cancer: A case reportGiacomo Barchiesi, Eriseld Krasniqi, Maddalena Barba, et al.
Breast Cancer Research and Treatment|August 14, 2014
Aromatase inhibitors for metastatic male breast cancer: molecular, endocrine, and clinical considerationsMarcello Maugeri-Saccà, Maddalena Barba, Patrizia Vici, et al.
World Journal of Radiology|July 29, 2015
Non-invasive diagnostic imaging of colorectal liver metastasesPier Paolo Mainenti, Federica Romano, Laura Pizzuti, et al.
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
Tumori|October 26, 2013
Unusual long-lasting cutaneous complete response to lapatinib and capecitabine in a heavily pretreated HER2-positive plurimetastatic breast cancer patientLaura Pizzuti, Domenico Sergi, Maddalena Barba, et al.
Immunotherapy|June 4, 2020
Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitorsPatrizia Vici, Laura Pizzuti, Eriseld Krasniqi, et al.
Journal of Clinical Medicine|February 21, 2019
Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast CancerMarco Mazzotta, Eriseld Krasniqi, Giacomo Barchiesi, et al.
Medicine|August 7, 2020
Case report: 5-year progression free survival and complete liver response in a patient with metastatic breast cancer treated with everolimus plus exemestaneEriseld Krasniqi, Giacomo Barchiesi, Marco Mazzotta, et al.
International Journal of Medical Sciences|April 16, 2021
Burnout of health care providers during the COVID-19 pandemic: Focus on Medical OncologistsPatrizia Vici, Eriseld Krasniqi, Laura Pizzuti, et al.
Frontiers in Oncology|July 31, 2023
Prognostic value of [18F]-FDG PET/CT in patients with meta-static breast cancer treated with cyclin-dependent inhibitorsAlessio Annovazzi, Sandra Rea, Daria Maccora, et al.
Anticancer Research|August 5, 2006
Tissue microarray analysis of FAS, Bcl-2, Bcl-x, ER, PgR, Hsp60, p53 and Her2-neu in breast carcinomaValeria Sebastiani, Claudio Botti, Ugo Di Tondo, et al.
Medicine|September 14, 2019
Highly durable response to capecitabine in patient with metastatic estrogen receptor positive breast cancer: A case reportGiacomo Barchiesi, Eriseld Krasniqi, Maddalena Barba, et al.
Breast Cancer Research and Treatment|August 14, 2014
Aromatase inhibitors for metastatic male breast cancer: molecular, endocrine, and clinical considerationsMarcello Maugeri-Saccà, Maddalena Barba, Patrizia Vici, et al.
World Journal of Radiology|July 29, 2015
Non-invasive diagnostic imaging of colorectal liver metastasesPier Paolo Mainenti, Federica Romano, Laura Pizzuti, et al.
Pageof 12